TFEB and fatty liver disease: Carmine et al. suggested that TFEB might be a novel therapeutic target for disorders of lipid metabolism, such as fatty liver disease, and that TFEB exerts global transcriptional control on lipid catabolism via PGC-1α and PPARα [14].